Glucocorticoid interaction with bone marrow lymphoblast receptors in acute leukemia
β Scribed by A. S. Dukhanin; T. A. Erina; N. N. Bulaeva; V. M. Chernov; L. I. Stankevich; K. L. Kondratchik; A. L. Lobanovskii
- Book ID
- 104970895
- Publisher
- Springer US
- Year
- 1993
- Tongue
- English
- Weight
- 299 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Localized bone marrow relapse is rare in acute lymphoblastic leukemia. Discordant bone marrow specimens were found in an 11-year-old asymptomatic girl who had been in remission for six years and off chemotherapy for 2 1/2 years. One bone marrow sample showed marked leukemic infiltration, whereas mar
Ten patients age 13-52 years with acute lymphoblastic leukemia (ALL) in first complete remission (CR) (1), second CR (6), or relapse (3) were treated with cyclophosphamide 50 mg/kg daily x 4 and total body irradiation 3 Gy daily x 4 followed by infusion of autologous marrow purged with 4-hydroperoxy
## Abstract Two children with bone marrow necrosis at diagnosis or at relapse of acute lymphoblastic leukemia (ALL) had thrombotic complications 15 and 17 days after starting remission induction therapy including prednisone, vincristine, and Lβasparaginase. The close temporal relationship of these
## Abstract In a retrospective review which covered the whole Dutch childhood population of approximately 3 million children we studied the prognosis in 164 children with acute lymphoblastic leukemia (ALL) who were initially treated between 1973 and 1983, and who had an isolated bone marrow relapse